During the past decade, Hospital San Roque conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 11 clinical trials were completed, i.e. on average, 64.7% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 9 clinical trials were completed. i.e. 90% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital San Roque" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Janssen Research & Development, LLC" with 4 trials sponsored, "Pfizer" with 2 trials sponsored, "Argentinian Intensive Care Society" with 1 trials sponsored and "Astellas Pharma Inc" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital San Roque" #1 collaborator was "ARTTIC International Management Services" with 1 trials as a collaborator, "AbCellera Biologics Inc." with 1 trials as a collaborator, "Allergan" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Basilea Pharmaceutica International Ltd" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Hospital San Roque" are "COVID-19" (3 trials), "Complicated Intra-abdominal Infection" (2 trials), "Covid19" (2 trials), "Influenza A" (2 trials) and "Acute Coronary Syndrome" (1 trials). Many other conditions were trialed in "Hospital San Roque" in a lesser frequency.

Most popular intervention types in "Hospital San Roque" are "Drug" (19 trials), "Other" (2 trials), "Biological" (1 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "ATM-AVI" (2 trials), "Pimodivir 600 mg" (2 trials), "SOC Treatment" (2 trials) and "Apabetalone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital San Roque" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Hospital San Roque". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Hospital San Roque, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital San Roque, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".